Elevation Oncology
Biotechnology Research • 
Boston, Massachusetts, United States • 11-20 Employees
Company overview
| Headquarters | 101 Federal St, Suite 1900, Boston, Massachusetts 02110, US |
| Phone number | +17163711125 |
| Website | |
| Founded | 2019 |
| Employees | 11-20 |
| Socials |
Key Contacts at Elevation Oncology
Anthony Garrity
Senior Director Of Information Technology
Darcy Mootz
Independent Board Director
Jaclyn Cleveland
Senior Director, Program Management
Jaya Srivastava
Senior Director Clinical Sciences And Development; Medical Strategy
Paul A. Orth
Senior Director Of Regulatory Sciences
Gracie Xuefei Tong
Senior Director Of Investor Relations & Corporate Communications
Elizabeth Burton
Director, Program Management
Eddie Kim
Senior Director, Financial Planning & Analysis
Andrea Cronican
East Regional Director, Medical Science Liaison
Peter Hintze
Director, Analytical Sciences
Elevation Oncology Email Formats
Elevation Oncology uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@elevationoncology.com), used 94.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@elevationoncology.com | 94.1% |
{first initial}.{last name} | j.doe@elevationoncology.com | 5.9% |
About Elevation Oncology
Elevation Oncology is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. We are rethinking drug development by seeking out innovative, selective cancer therapies that can be matched to a patient’s unique tumor characteristics. Our lead candidate, EO-3021, is a potential best-in-class antibody drug conjugate (ADC) designed to target Claudin 18.2, a clinically validated molecular target. EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. We are working to rapidly advance EO-3021 into the clinic in the US across a range of solid tumor indications, as well as exploring other opportunities through new or existing partnerships and business development opportunities to expand our novel oncology pipeline.
Elevation Oncology revenue & valuation
| Annual revenue | $1,368,880 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,400,000 |
| Total funding | $50,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Elevation Oncology has 9 employees across 6 departments.
Departments
Number of employees
Elevation Oncology Tech Stack
Discover the technologies and tools that power Elevation Oncology's digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
UI frameworks
JavaScript libraries
JavaScript libraries
Miscellaneous
Analytics
Analytics
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Ireland
Italy
United Kingdom
Belgium
Frequently asked questions
4.8
40,000 users
